AI vs. Human Scribes: What Actually Works?

In partnership with

Welcome, AI Entrepreneurs!

Physicians now spend nearly twice as much time documenting as they do seeing patients.

Four thousand clicks per shift. Hours of after-hours charting. The rise of “pajama time.”

Documentation is no longer a side task. It is shaping clinician morale, operational cost, and patient experience.

In today’s issue, I break down the documentation dilemma: AI scribes versus human scribes, and what actually moves the needle.

In today’s AIpreneurs Insights: 

• Spotlight of the Week: The Documentation Dilemma: AI vs. Human Scribes

• Become the Human in the Loop in Healthcare AI

• Top 3 AI Business Search Trends of the Week

• Top 5 AI Tools to Think Faster and Execute Better in 2026

• Free Resource: The Human-in-the-Loop Healthcare AI Decision Guide

The Documentation Dilemma: AI vs. Human Scribes

This week’s infographic compares the operational and financial realities of AI scribes and human scribes.

AI scribes offer significantly lower monthly cost, near real-time note completion, and measurable reductions in documentation-related burnout. Human scribes, while valuable in certain environments, come with higher costs, longer turnaround times, and limited scalability.

But the real decision is not simply AI versus human.

The real question is whether documentation is designed around workflow, safety, and oversight.

AI scribes can reduce friction dramatically when implemented correctly. Poor rollout can create new risks, duplication, or accuracy concerns.

If you are evaluating documentation solutions, the conversation should include workflow integration, validation, and accountability.

If you want to review whether an AI scribe fits your practice or health system, we can walk through it together. You can book a call using my Calendly link.

Not subscribed yet?

Are you keeping up with the latest in AI for business and healthcare? Our newsletter is essential reading for anyone navigating the AI landscape. It’s free, and industry leaders from top companies like Google, Hubspot, and Meta are already on board.

Sign up for our newsletter with just one click—it's completely free!!!

Big News: Our Program Is Live!!!

Choosing between AI and human scribes is not just a budget decision.

It is a governance decision.

In Become the Human in the Loop in Healthcare AI, I teach clinicians and leaders how to evaluate AI documentation tools, assess risk, validate outputs, and implement responsibly.

The goal is not to automate blindly. It is to deploy AI where it reduces burden while preserving clinical oversight and trust.

Documentation is one of the highest-leverage areas for AI in healthcare. But it must be implemented intentionally.

Check out the structured program HERE: https://www.umerkhanmd.com/buy_videoprogram

Turn AI into Your Income Engine

Ready to transform artificial intelligence from a buzzword into your personal revenue generator?

HubSpot’s groundbreaking guide "200+ AI-Powered Income Ideas" is your gateway to financial innovation in the digital age.

Inside you'll discover:

• A curated collection of 200+ profitable opportunities spanning content creation, e-commerce, gaming, and emerging digital markets—each vetted for real-world potential

• Step-by-step implementation guides designed for beginners, making AI accessible regardless of your technical background

• Cutting-edge strategies aligned with current market trends, ensuring your ventures stay ahead of the curve

Download your guide today and unlock a future where artificial intelligence powers your success. Your next income stream is waiting.

Get Your Guide

1. States vs. White House: Who Controls AI in Insurance?

A growing number of Republican- and Democratic-led states are passing laws to regulate how health insurers use AI, especially in coverage decisions and prior authorizations. Meanwhile, a federal executive order seeks to limit state authority, arguing that AI innovation must remain free from “excessive” regulation.

The Details:

• At least nine states have enacted or proposed laws restricting how AI can be used in insurance coverage decisions, including requirements for human oversight and algorithm transparency.

• A recent executive order from the White House aims to preempt most state-level AI regulations, citing national competitiveness and innovation concerns.

• Lawmakers and physicians argue AI-driven denials worsen an already opaque prior authorization process, while insurers insist AI improves efficiency and speeds approvals.

• Legal scholars question whether the executive branch has the constitutional authority to override state AI laws without congressional action.

Why it Matters: 

AI in insurance sits at the intersection of healthcare, technology, and federalism. If automated systems increasingly influence coverage approvals, transparency and accountability become critical — especially when patient access to care is at stake. The broader battle may determine not just how insurers use AI, but who ultimately controls AI governance in America: states, Congress, or the executive branch.

Find out more about it here: https://www.governing.com/artificial-intelligence/red-and-blue-states-want-to-regulate-ai-in-insurance-the-white-house-disagrees?utm_source=chatgpt.com

2. Investor Loyalty Is Fading in the AI Gold Rush

As OpenAI and Anthropic raise record-breaking funding rounds, a surprising trend has emerged: many of the same venture firms are investing in both rivals. In the AI boom, traditional notions of investor loyalty appear to be giving way to opportunity and scale.

The Details:

• At least a dozen investors backing OpenAI are also participating in Anthropic’s latest $30 billion raise, including major venture firms like Sequoia, Founders Fund, and Insight Partners.

• While crossover investments are common among hedge funds and asset managers, they have historically been rare in venture capital, where firms often position themselves as strategic allies to a single company.

• The scale of AI fundraising — with OpenAI reportedly nearing a $100 billion round — is reshaping norms, as firms chase exposure to the sector’s explosive growth.

• Some investors are still drawing lines, backing only one of the major labs, but the longstanding expectation of exclusivity is clearly weakening.

Why it Matters: 

AI is testing the cultural foundations of venture capital. When investors back direct competitors, questions arise around confidentiality, fiduciary duty, and founder trust. As frontier AI companies scale into infrastructure-heavy giants, capital allocation may increasingly favor portfolio exposure over loyalty — and founders may need to scrutinize investor conflicts more closely before signing their next term sheet.

Read more about it here: https://techcrunch.com/2026/02/23/with-ai-investor-loyalty-is-almost-dead-at-least-a-dozen-openai-vcs-now-also-back-anthropic/

3. Google VP Says Two AI Startup Models May Not Survive

A senior Google executive is warning that two popular AI startup models — LLM wrappers and AI aggregators may struggle to survive long term. As foundational model providers expand their capabilities, startups without deep differentiation risk being squeezed out.

The Details:

• LLM wrappers: startups that layer a simple UI or niche feature on top of models like GPT, Claude, or Gemini are losing favor unless they build strong intellectual property or vertical specialization.

• Thin differentiation is no longer enough; investors and customers now expect defensible moats, domain expertise, or proprietary workflows.

• AI aggregators, which route queries across multiple models via a unified interface or API, face pressure as model providers add enterprise features and reduce the need for intermediaries.

• The dynamic mirrors early cloud computing, where startups reselling infrastructure were displaced once AWS and others expanded their own tooling.

Why it Matters: 

The first wave of generative AI rewarded speed and surface-level innovation. The next phase will reward depth, defensibility, and proprietary advantage. As foundational model providers move up the stack, startups must either own a critical workflow or risk becoming redundant. In the AI economy, the real question is no longer who can build on top — but who can build something that can’t be easily absorbed.

Find out more about it here: https://techcrunch.com/2026/02/21/google-vp-warns-that-two-types-of-ai-startups-may-not-survive/

Stay tuned for more updates in our next newsletter!

Top 5 AI Tools to Think Faster and Execute Better in 2026

1. Perplexity AI

🔗 https://www.perplexity.ai

Perplexity combines search and AI reasoning to deliver fast, citation-backed answers. Ideal for research, market analysis, and staying updated without digging through dozens of tabs. Free and paid plans available.

2. Claude

🔗 https://claude.ai

Claude excels at long-form reasoning, document analysis, and structured thinking. Useful for reviewing contracts, drafting policy documents, and breaking down complex ideas. Free and paid plans available.

3. Gamma

🔗 https://gamma.app

Gamma uses AI to instantly generate presentations, pitch decks, and structured documents. Great for founders, consultants, and professionals who need polished materials quickly. Free tier available.

4. Opus Clip

🔗 https://www.opus.pro

Opus Clip turns long-form videos into short, viral-ready clips using AI. Ideal for creators and professionals building personal brands across social platforms. Free and paid plans available.

5. Replit Ghostwriter

🔗 https://replit.com

Replit’s AI coding assistant helps generate, debug, and explain code in real time. Useful for non-technical founders experimenting with prototypes or developers speeding up workflows. Free and paid plans available.

𝐘𝐎𝐔 𝐒𝐇𝐎𝐔𝐋𝐃 𝐇𝐄𝐀𝐑 𝐓𝐇𝐈𝐒.

𝐀𝐈 𝐢𝐬 𝐞𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐭 𝐚𝐭 𝐨𝐧𝐞 𝐭𝐡𝐢𝐧𝐠: 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧.

Reduce readmissions.
Shorten length of stay.
Improve coding accuracy.

It sees variables.
Weights probabilities.
Optimizes for the metric it’s given.

But healthcare IS NOT a math problem.
Because every optimization has a shadow.

➡️ 𝐃𝐢𝐬𝐜𝐡𝐚𝐫𝐠𝐞 𝐚 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐟𝐚𝐬𝐭𝐞𝐫
Did we really shorten recovery?
or just move the complication to another facility?

➡️ 𝐓𝐢𝐠𝐡𝐭𝐞𝐧 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐞𝐦𝐩𝐥𝐚𝐭𝐞𝐬
Did we improve compliance?
or silence nuance?

➡️ 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐬𝐮𝐩𝐩𝐨𝐫𝐭
Did we reduce error
or shift accountability?

➡️ 𝐌𝐚𝐜𝐡𝐢𝐧𝐞𝐬 𝐨𝐩𝐭𝐢𝐦𝐢𝐳𝐞 𝐟𝐨𝐫 𝐭𝐚𝐫𝐠𝐞𝐭𝐬.
but humans carry consequences.

Only a clinician feels the weight of telling a family:
“𝐖𝐞 𝐬𝐡𝐨𝐮𝐥𝐝 𝐡𝐚𝐯𝐞 𝐜𝐚𝐮𝐠𝐡𝐭 𝐭𝐡𝐢𝐬 𝐬𝐨𝐨𝐧𝐞𝐫.”

Only a human understands the moral cost
of a technically correct but contextually wrong decision.

This is why supervision matters.

In AI scribes.
In workflow automation.
In clinical decision support.

If an AI scribe optimizes for speed
but subtly alters tone, emphasis, or clinical framing...

That’s not just formatting.
That’s medico-legal exposure.
Continuity risk. Future misinterpretation.

The future of healthcare AI isn’t about better optimization.
It’s about responsible integration.

𝐃𝐞𝐬𝐢𝐠𝐧 𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐭𝐡𝐚𝐭:
- Preserve judgment
- Surface uncertainty
- Optimize mechanics
- Keep humans accountable

Because in medicine,
Outcomes can be optimized.
Consequences must be understood.

If you’re deploying AI in documentation or clinical workflows,
Make sure it improves metrics, without outsourcing responsibility.

That’s the real benchmark!!!

Become An AI Expert In Just 5 Minutes

If you’re a decision maker at your company, you need to be on the bleeding edge of, well, everything. But before you go signing up for seminars, conferences, lunch ‘n learns, and all that jazz, just know there’s a far better (and simpler) way: Subscribing to The Deep View.

This daily newsletter condenses everything you need to know about the latest and greatest AI developments into a 5-minute read. Squeeze it into your morning coffee break and before you know it, you’ll be an expert too.

Subscribe right here. It’s totally free, wildly informative, and trusted by 600,000+ readers at Google, Meta, Microsoft, and beyond.

Want to work with Me? Here’s how:

I help companies with AI integration and with other technology and development requirements. Book a Strategy Call. (https://calendly.com/dr-umerkhan/available-for-meeting)

Promote Your Product: I’ll share your product with my 15k followers on LinkedIn. Reply “promo” if interested.

If you enjoyed this newsletter, please forward it to your friends and colleagues.

Follow me on LinkedIn, Youtube, and X/Twitter to see my latest content.

My Latest LinkedIn Posts

Stay Tuned

Stay tuned for more updates on AI trends, tools, and insights in our next newsletter.